GALECTIN THERAPEUTICS INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | -208.3% | -208.3% | -135.7% |
| FY2017 | 3,063.2% | 3,063.2% | -390.2% |
| FY2018 | -268.6% | -268.6% | -154.3% |
| FY2019 | -30.3% | -30.3% | -27.4% |
| FY2020 | -104.4% | -104.4% | -79.3% |
| FY2021 | -3,418.5% | -3,418.5% | -73.0% |
| FY2022 | 114.3% | 114.3% | -182.2% |
| FY2023 | 66.3% | 66.3% | -145.6% |
| FY2024 | 44.9% | 44.9% | -268.9% |
| FY2025 | 24.1% | 24.1% | -157.9% |